SE8207224L - Nya aromatiska aminoalkoxiderivat, deras framstellning och deras terapeutiska anvendning - Google Patents

Nya aromatiska aminoalkoxiderivat, deras framstellning och deras terapeutiska anvendning

Info

Publication number
SE8207224L
SE8207224L SE8207224A SE8207224A SE8207224L SE 8207224 L SE8207224 L SE 8207224L SE 8207224 A SE8207224 A SE 8207224A SE 8207224 A SE8207224 A SE 8207224A SE 8207224 L SE8207224 L SE 8207224L
Authority
SE
Sweden
Prior art keywords
derivatives
coxide
aminoal
preparation
therapeutic use
Prior art date
Application number
SE8207224A
Other languages
English (en)
Other versions
SE8207224D0 (sv
SE453916B (sv
Inventor
G Bourgery
A Lacour
B Pourrias
R Santamaria
Original Assignee
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8124244A external-priority patent/FR2518992A1/fr
Priority claimed from FR8221053A external-priority patent/FR2537970B1/fr
Application filed by Delalande Sa filed Critical Delalande Sa
Publication of SE8207224D0 publication Critical patent/SE8207224D0/sv
Publication of SE8207224L publication Critical patent/SE8207224L/sv
Publication of SE453916B publication Critical patent/SE453916B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/54Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition of compounds containing doubly bound oxygen atoms, e.g. esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
SE8207224A 1981-12-24 1982-12-17 Nya aromatiska aminoalkoxiderivat, deras framstellningssett och lekemedel anvendbart som kalciumantagonist SE453916B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8124244A FR2518992A1 (fr) 1981-12-24 1981-12-24 Nouveaux derives aminoalcoxy aromatiques, leur procede de preparation et leur application en therapeutique
FR8221053A FR2537970B1 (fr) 1982-12-15 1982-12-15 Nouveaux derives aminoalkoxy aromatiques, leur procede de preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
SE8207224D0 SE8207224D0 (sv) 1982-12-17
SE8207224L true SE8207224L (sv) 1983-06-25
SE453916B SE453916B (sv) 1988-03-14

Family

ID=26222677

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8207224A SE453916B (sv) 1981-12-24 1982-12-17 Nya aromatiska aminoalkoxiderivat, deras framstellningssett och lekemedel anvendbart som kalciumantagonist
SE8505219A SE8505219D0 (sv) 1981-12-24 1985-11-06 Derives aminoalkoxy aromatiques et leur procede de preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8505219A SE8505219D0 (sv) 1981-12-24 1985-11-06 Derives aminoalkoxy aromatiques et leur procede de preparation

Country Status (13)

Country Link
US (3) US4536500A (sv)
JP (1) JPH04210944A (sv)
AU (1) AU9193482A (sv)
CA (1) CA1197243A (sv)
CH (2) CH661509A5 (sv)
DE (1) DE3247860A1 (sv)
ES (1) ES518518A0 (sv)
GB (2) GB2113680B (sv)
GR (1) GR78370B (sv)
IT (1) IT1191152B (sv)
LU (1) LU84548A1 (sv)
NL (1) NL8204978A (sv)
SE (2) SE453916B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017572A (en) * 1988-04-22 1991-05-21 Delalande S.A. Derivatives of 1-[3-(4-hydroxyphenyl) 1-hydroxy 1-propyl] benzene substituted in position 2 by an aminoalkyleneoxy chain, the method of preparing same and the application thereof to therapeutics
US5270325A (en) * 1988-07-28 1993-12-14 Basf Aktiengesellschaft P-hydroxy phenone derivatives used in the treatment of cardiac arrhythmia
KR0139296B1 (ko) * 1988-11-21 1998-05-15 가와무라 시게꾸니 칼콘 유도체 및 그 제조 방법
US4937235A (en) * 1989-01-23 1990-06-26 American Cyanamid Company 3- or 4-substituted oxotremorine derivatives
FR2646670A1 (fr) * 1989-05-05 1990-11-09 Delalande Sa Utilisation de derives aminoalkoxy aromatiques pour le traitement des troubles du systeme cerebrovasculaire
US5214046A (en) * 1989-07-27 1993-05-25 Hoffmann-La Roche Inc. Substituted aminoalkoxybenzene anti-fungicidal compositions and use
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
US5356891A (en) * 1989-09-22 1994-10-18 Witiak Donald T Phenylalkyl amine derivatives having anti-ischaemic activity
WO1991007958A1 (en) * 1989-12-06 1991-06-13 Vsesojuzny Kardiologichesky Nauchny Tsentr Pharmaceutical preparation-protector of myocardium under ischemia and reperfusion
GB9321811D0 (en) * 1993-10-22 1993-12-15 Smithkline Beecham Plc Pharmaceuticals
FR2734831B1 (fr) * 1995-05-29 1997-07-11 Oreal Composition solide expansee dont la matrice est constituee d'un reseau alveolaire amidonne et contenant des particules de polyamide spheroidales calibrees et utilisations en application topique
ES2239793T3 (es) * 1997-08-07 2005-10-01 Eli Lilly And Company Compuestos de 1-(4-(alcoxi sustituido)bencil)naftaleno con actividad inhibidora de estrogenos.
US6054246A (en) * 1998-07-01 2000-04-25 Polaroid Corporation Heat and radiation-sensitive imaging medium, and processes for use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB377464A (en) * 1930-08-28 1932-07-28 Chem Ind Basel Manufacture of substituted aromatic ketones
US2668850A (en) * 1952-04-24 1954-02-09 Hoffmann La Roche Phenyl-phenethyl ketones
GB730922A (en) * 1952-04-24 1955-06-01 Roche Products Ltd Aromatic amino-ketones and acid addition salts thereof and a process for the manufacture of same
GB872997A (en) * 1957-01-26 1961-07-19 Pharmacia Ab Substituted ún-aminoalkoxy-acyl benzenes and processes for their manufacture
GB905903A (en) * 1960-05-25 1962-09-12 Guidotti & C Spa Labor Dialkylaminoethoxyketones having a coronary-dilating action and methods of preparingthem
US3077472A (en) * 1961-03-21 1963-02-12 Univ Kansas Res Foundation 3-[4-(aminoalkoxy)-phenyl]-4-(4-oxyphenyl)-alkanes and alkenes
GB1063744A (en) * 1964-05-25 1967-03-30 American Cyanamid Co 4-substituted-4'-tertiary aminoalkoxy biphenyls
GB1111338A (en) * 1964-07-24 1968-04-24 Fisons Pharmaceuticals Ltd Aralkyl substituted resorcinols
FR5733M (sv) * 1966-09-27 1968-01-22
GB1388088A (en) * 1973-05-16 1975-03-19 Inst Med Parazitologii I Tropi N-b-2-acetyl-4-chloro-phenoxy-ethyl-n,n-dimethyl-n-benzyl- ammonium-p-chlorobenzene sulphonate method for preparing same and medicinal preparation based thereon

Also Published As

Publication number Publication date
GB2113680B (en) 1986-08-13
US4732896A (en) 1988-03-22
GR78370B (sv) 1984-09-26
GB8506732D0 (en) 1985-04-17
SE8207224D0 (sv) 1982-12-17
ES8308864A1 (es) 1983-10-01
SE8505219L (sv) 1985-11-06
GB2154587A (en) 1985-09-11
CH655313A5 (fr) 1986-04-15
CH661509A5 (fr) 1987-07-31
NL8204978A (nl) 1983-07-18
GB2113680A (en) 1983-08-10
AU9193482A (en) 1983-09-01
CA1197243A (en) 1985-11-26
JPH04210944A (ja) 1992-08-03
SE453916B (sv) 1988-03-14
US4536500A (en) 1985-08-20
GB2154587B (en) 1986-08-20
IT1191152B (it) 1988-02-24
DE3247860C2 (sv) 1993-08-05
LU84548A1 (fr) 1984-10-22
ES518518A0 (es) 1983-10-01
SE8505219D0 (sv) 1985-11-06
IT8224964A0 (it) 1982-12-23
US4831051A (en) 1989-05-16
DE3247860A1 (de) 1983-07-28

Similar Documents

Publication Publication Date Title
FI20001231A (sv) 2-Deoxi-2,3-didehydro-N-acetylaneuraminsyrans derivat och analoger och deras användning vom antivirala ämen
DE3581699D1 (de) Bis-dimethoxymethyl(trimethoxybenzyl)isochinolinium-salze, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
SE8207224L (sv) Nya aromatiska aminoalkoxiderivat, deras framstellning och deras terapeutiska anvendning
FI833918A0 (fi) -karboliner, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat
MX9201760A (es) Quinoxalinas, procedimiento para su preparacion y su empleo.
FI822203A0 (fi) Nya 2-aryl-3,4-diaza-bicyklo/4,n,0/-alken-(2)-oner-(5), foerfarande foer deras framstaellning och dessa innehaollande laekemedel
FI851261L (fi) Substituerade bensopyraner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ES2054650T3 (es) Fenilacetonitrilos basicamente substituidos, su obtencion y medicamentos que los contienen.
ATE92469T1 (de) Neue alpha-aminocarbonsaeure-derivate, ihre herstellung und verwendung.
ES2061532T3 (es) Derivados sustituidos de acido piridina-2,4-dicarboxilico, procedimientos para su preparacion, utilizacion de los mismos, asi como medicamentos a base de estos compuestos.
DK319785D0 (da) Acetyleniske phenoxypropanolderivater
ES8706138A1 (es) Procedimiento para la obtencion de nuevas benzoilureas
DE3853958D1 (de) Substituierte Pyridin-Verbindungen, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
ATE92070T1 (de) Azachromanderivate.
ES2061550T3 (es) Vinilcefalosporinas substituidas, procedimiento para su preparacion y su uso como medicamento.
ES503920A0 (es) Procedimiento de preparacion de mononitratos de 1.4,3.6- dianhidro-hexito sustituidos en 2-0 y 5-0
ES8605247A1 (es) Procedimiento para la obtencion de arisulfonilguanidinas sustituidas
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
FI933231A (fi) Acylaminoalkylidenhydroxibisfosfonsyror anvaendningsbara vid terapi av benledsjukdomar
ES8703855A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinotriazina
FI880063A (fi) Nya derivat av 4,4-dimetyl tetrahydropyr-2-on, foerfarande foer deras framstaellning och deras anvaendning vid syntes av pyretinoidfoereningar.
JPS5427578A (en) 1-carboxyalkylcarbamoyl-5-fluorouracil derivatives and their preparation
TR21738A (tr) Florafenoksibenzil esterler,bunlarin hazirlanmasi ve pestisid olarak kullanimi
ATE73339T1 (de) Pharmazeutisches kombinationspraeparat.
JPS5344573A (en) Optical active 2-piperidineethanols and their preparation

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8207224-0

Effective date: 19940710

Format of ref document f/p: F